Mayne Pharma MAYNF Stock
Mayne Pharma Price Chart
Mayne Pharma MAYNF Financial and Trading Overview
| Mayne Pharma stock price | 4.25 USD |
| Previous Close | 2.57 USD |
| Open | 2.57 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 2.57 - 2.57 USD |
| 52 Week Range | 0.15 - 5.86 USD |
| Volume | 13 USD |
| Avg. Volume | 525 USD |
| Market Cap | 234.36M USD |
| Beta (5Y Monthly) | 0.992337 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.99 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | January 18, 2023 |
| 1y Target Est | N/A |
MAYNF Valuation Measures
| Enterprise Value | 132.47M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.62403333 |
| Price/Book (mrq) | 0.28410348 |
| Enterprise Value/Revenue | 0.353 |
| Enterprise Value/EBITDA | -1.565 |
Trading Information
Mayne Pharma Stock Price History
| Beta (5Y Monthly) | 0.992337 |
| 52-Week Change | -24.41% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.86 USD |
| 52 Week Low | 0.15 USD |
| 50-Day Moving Average | 2.55 USD |
| 200-Day Moving Average | 2.93 USD |
MAYNF Share Statistics
| Avg. Volume (3 month) | 525 USD |
| Avg. Daily Volume (10-Days) | 350 USD |
| Shares Outstanding | 85.07M |
| Float | 60.52M |
| Short Ratio | N/A |
| % Held by Insiders | 24.82% |
| % Held by Institutions | 16.47% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 20.51% |
| Operating Margin (ttm) | -39.92% |
| Gross Margin | 30.43% |
| EBITDA Margin | -22.53% |
Management Effectiveness
| Return on Assets (ttm) | -6.32% |
| Return on Equity (ttm) | -43.54% |
Income Statement
| Revenue (ttm) | 375.56M USD |
| Revenue Per Share (ttm) | 4.53 USD |
| Quarterly Revenue Growth (yoy) | -32.70% |
| Gross Profit (ttm) | 171.03M USD |
| EBITDA | -84641000 USD |
| Net Income Avi to Common (ttm) | -326335008 USD |
| Diluted EPS (ttm) | -2.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 175.54M USD |
| Total Cash Per Share (mrq) | 1.99 USD |
| Total Debt (mrq) | 81.23M USD |
| Total Debt/Equity (mrq) | 10.18 USD |
| Current Ratio (mrq) | 1.454 |
| Book Value Per Share (mrq) | 9.046 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -64414000 USD |
| Levered Free Cash Flow (ttm) | -150407872 USD |
Profile of Mayne Pharma
| Country | United States |
| State | SA |
| City | Salisbury South |
| Address | 1538 Main North Road |
| ZIP | 5106 |
| Phone | 61 8 8209 2666 |
| Website | https://www.maynepharma.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Q&A For Mayne Pharma Stock
What is a current MAYNF stock price?
Mayne Pharma MAYNF stock price today per share is 4.25 USD.
How to purchase Mayne Pharma stock?
You can buy MAYNF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mayne Pharma?
The stock symbol or ticker of Mayne Pharma is MAYNF.
Which industry does the Mayne Pharma company belong to?
The Mayne Pharma industry is Drug Manufacturers-General.
How many shares does Mayne Pharma have in circulation?
The max supply of Mayne Pharma shares is 92.02M.
What is Mayne Pharma Price to Earnings Ratio (PE Ratio)?
Mayne Pharma PE Ratio is now.
What was Mayne Pharma earnings per share over the trailing 12 months (TTM)?
Mayne Pharma EPS is -0.99 USD over the trailing 12 months.
Which sector does the Mayne Pharma company belong to?
The Mayne Pharma sector is Healthcare.